Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00445653 · ClinicalTrials.gov registry record
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 170
- Enrollment target
NCT00445653: Completed study, sponsored by Massachusetts General Hospital.
NCT00445653 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00445653 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
RATIONALE: A study that evaluates DNA changes and other disease-related health information in patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding may help doctors learn more about the risk factors for Barrett's esophagus. PURPOSE: This clinical trial is looking at DNA changes and other disease-related health information as risk factors for Barrett's esophagus in patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2005-08 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00445653
The ClinicalTrials.gov registry entry for NCT00445653 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00445653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00445653 about?
NCT00445653 is a clinical study titled "Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding". RATIONALE: A study that evaluates DNA changes and other disease-related health information in patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding may help doctors learn more about the risk factors for Barrett's esophagus. PURPOSE: This clinical trial is looking ...
What is the current status of trial NCT00445653?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2005-08. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT00445653?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.